Charles River Labs (CRL) PT Raised to $104 at Jefferies Following Strong 4Q Results

February 15, 2017 8:11 AM

Jefferies analyst David Windley reiterates Buy rating and raises price target on Charles River Laboratories (NYSE: CRL), as ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found